1. Gilbert C, Fielder A, Gordillo L, Quinn G, Semiglia R, Visintin P, Zin A. International NO-ROP Group. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics. 2005. 115:e518–e525.
2. Gilbert C. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev. 2008. 84:77–82.
3. Good WV. Early Treatment for Retinopathy of Prematurity Cooperative Group. The Early Treatment for Retinopathy of Prematurity Study: structural findings at age 2 years. Br J Ophthalmol. 2006. 90:1378–1382.
4. Austeng D, Källen KB, Ewald UW, Wallin A, Holmström GE. Treatment for retinopathy of prematurity in infants born before 27 weeks of gestation in Sweden. Br J Ophthalmol. 2010. 94:1136–1139.
5. Wilson-Costello D, Friedman H, Minich N, Fanaroff AA, Hack M. Improved survival rates with increased neurodevelopmental disability for extremely low birth weight infants in the 1990s. Pediatrics. 2005. 115:997–1003.
6. Stoll BJ, Hansen NI, Bell EF, Shankaran S, Laptook AR, Walsh MC, Hale EC, Newman NS, Schibler K, Carlo WA, et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics. 2010. 126:443–456.
7. Section on Ophthalmology American Academy of Pediatrics. American Academy of Ophthalmology. American Association for Pediatric Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2006. 117:572–576.
8. Wilkinson AR, Haines L, Head K, Fielder AR. Guideline Development Group of the Royal College of Paediatrics and Child Health. Royal College of Ophthalmologists. British Association of Perinatal Medicine. UK retinopathy of prematurity guideline. Eye (Lond). 2009. 23:2137–2139.
9. Early Treatment For Retinopathy Of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003. 121:1684–1694.
10. Good WV. Early Treatment for Retinopathy of Prematurity Cooperative Group. Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc. 2004. 102:233–248.
11. Palmer EA, Flynn JT, Hardy RJ, Phelps DL, Phillips CL, Schaffer DB, Tung B. Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology. 1991. 98:1628–1640.
12. International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol. 2005. 123:991–999.
13. Austeng D, Källen KB, Ewald UW, Jakobsson PG, Holmström GE. Incidence of retinopathy of prematurity in infants born before 27 weeks' gestation in Sweden. Arch Ophthalmol. 2009. 127:1315–1319.
14. Muether PS, Kribs A, Hahn M, Schumacher J, Eifinger F, Kirchhof B, Roth B, Fauser S. No advanced retinopathy of prematurity stages 4 or 5 in a large high-risk German cohort. Br J Ophthalmol. 2012. 96:400–404.
15. Gunn DJ, Cartwright DW, Gole GA. Incidence of retinopathy of prematurity in extremely premature infants over an 18-year period. Clin Experiment Ophthalmol. 2012. 40:93–99.
16. Tan SZ, Dhaliwal C, Becher JC, Fleck B. Trends in the incidence of retinopathy of prematurity in Lothian, south-east Scotland, from 1990 to 2009. Arch Dis Child Fetal Neonatal Ed. 2012. 97:F310–F311.
17. Teed RG, Saunders RA. Retinopathy of prematurity in extremely premature infants. J AAPOS. 2009. 13:370–373.
18. Slidsborg C, Forman JL, Fielder AR, Crafoord S, Baggesen K, Bangsgaard R, Fledelius HC, Greisen G, la Cour M. Experts do not agree when to treat retinopathy of prematurity based on plus disease. Br J Ophthalmol. 2012. 96:549–553.
19. Austeng D, Källen KB, Hellström A, Tornqvist K, Holmström GE. Natural history of retinopathy of prematurity in infants born before 27 weeks' gestation in Sweden. Arch Ophthalmol. 2010. 128:1289–1294.
20. Austeng D, Källen KB, Hellström A, Jakobsson PG, Johansson K, Tornqvist K, Wallin A, Holmström GE. Screening for retinopathy of prematurity in infants born before 27 weeks' gestation in Sweden. Arch Ophthalmol. 2011. 129:167–172.
21. Can E, Bülül A, Uslu S, Cömert S, Bolat F, Nuhoğlu A. Effects of aggressive parenteral nutrition on growth and clinical outcome in preterm infants. Pediatr Int. 2012. doi:
10.1111/j.1442-200X.2012.03713.X.
22. Schaffer DB, Palmer EA, Plotsky DF, Metz HS, Flynn JT, Tung B, Hardy RJ. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Prognostic factors in the natural course of retinopathy of prematurity. Ophthalmology. 1993. 100:230–237.
23. Good WV, Hardy RJ, Dobson V, Pamer EA, Phelps DL, Quintos M, Tung B. Early Treatment for Retinopathy of Prematurity Cooperative Group. The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study. Pediatrics. 2005. 116:15–23.
24. Lad EM, Nguyen TC, Morton JM, Moshfeghi DM. Retinopathy of prematurity in the United States. Br J Ophthalmol. 2008. 92:320–325.
25. Hussain N, Clive J, Bhandari V. Current incidence of retinopathy of prematurity, 1989-1997. Pediatrics. 1999. 104:e26.
26. Shah VA, Yeo CL, Ling YL, Ho LY. Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore. Ann Acad Med Singapore. 2005. 34:169–178.